04/09/2023
In connection to David Nygren's thesis defence we are happy to announce a symposium on Fusobacterium necrophorum with faculty opponent Professor Robert Centor, University of Alabama, USA, and other experts from Sweden and Denmark. See program below.
Time: Thursday, September 7 from 9.30-16
Location: Room E16003, Forum Medicum.
Professor Robert Centor is a world leading expert on Lemierre's syndrome in addition to the criteria bearing his name.
Everyone is very welcome but seats are limited, so pre-registration is appreciated! Send an email to [email protected]
Lunch and fika will be served for pre-registrated participants, please state any allergies or other preferences.
Preliminary program:
9.30 - 10.00
Coffee and mingle
10.00 - 10.10
Welcome. Presentation of participants.
Karin Holm, MD Infectious diseases, Associate professor, Lund
10.15 - 10.45
The EUCAST disc diffusion susceptibility testing method for F. necrophorum and other frequently isolated anaerobic bacteria.
Erika Matuschek, Clinical scientist, EUCAST development laboratory, Växjö (zoom)
10.45 - 11.10
Protein FHA, a novel surface protein of F. necrophorum.
Olivia Engstrand, biomedical masters student, Lund
11.10 - 11.25
Break
11.25 - 11.50
Testing criteria for F. necrophorum tonsillitis.
Josefina Pagels, MD, Lund
11.50 - 12.15
The impact of social restrictions on the incidence and microbiology of peritonsillar abscess.
Tejs Ehlers Klug, MD ENT surgery, Associate professor, Aarhus
12.15 - 12.40
Bacterial findings in severe acute tonsillitis with or without peritonsillar phlegmon.
Tejs Ehlers Klug
12.40 - 13.40
Lunch break
13.40 - 14.00
Serum markers from patients with pharyngotonsillitis and pertonsillar abscess.
Åsa Gylfe, MD clinical microbiology, PhD, Umeå
14.00-14.40
A need for guidance
Robert Centor, MD internal medicine, Professor emeritus, University of Alabama, Birmingham
14.40 - 14.55
Break
14.55 - 15.20
A randomized controlled clinical trial of GAS-neg acute tonsillitis in primary health care - a comparison of phenoxymethylpenicillin and no antibiotic treatment. Report from an ongoing RCT.
Katarina Hedin, MD general medicin, Professor, Linköping
15.20 - 15.45
High prevalence of pharyngeal bacterial pathogens among healthy adolescents and young adults.
Martin Agerhäll, MD ENT surgery, PhD student, Umeå University
15.45 - 16.00
Concluding remarks
